Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037))

Cláudia M. Deus, Susana P. Pereira, Teresa Cunha-Oliveira, José Teixeira, Rui F. Simões, Fernando Cagide, Sofia Benfeito, Fernanda Borges, Nuno Raimundo, Paulo J. Oliveira

Research output: Contribution to journalComment/debatepeer-review

Abstract

2.3. Cell culture conditions Skin fibroblasts from five sporadic late-onset PD (sPD) male patients and five age- and sex-matched healthy controls were obtained from a cell line repository of the Coriell Institute for Medical Research, USA (www.coriell.org), and their detailed information was previously described [43]. The repository ID numbers of control fibroblasts used were: ND29178, ND29179, ND34770, ND35044, and ND38530; the repository ID numbers of sPD fibroblasts used were: ND34265, ND35320, ND35322, ND35976, and ND39999.

Original languageEnglish (US)
Article number102117
JournalRedox Biology
DOIs
StateAccepted/In press - 2021

All Science Journal Classification (ASJC) codes

  • Organic Chemistry
  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Corrigendum to ‘A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients’. [Redox Biology 45 (2021) 102037] (Redox Biology (2021) 45, (S2213231721001968), (10.1016/j.redox.2021.102037))'. Together they form a unique fingerprint.

Cite this